Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Ipsen today announced that it has expanded its collaboration and licensing agreement with Exelixis Inc for the development of Cabometyx cabozantinib in advanced pancreatic neuroendocrine tumors
BIOSENIC the clinicalstage company specializing in serious autoimmune and inflammatory diseases and cell therapy and its subsidiary Medsenic SAS today announce the signature of global licensing
This year the Hamburg based life sicences company Eppendorf SE is awarding its prestigious research prize for the th time The independent jury chaired by Prof Laura Machesky Cambridge UK selected Dr Clemens Plaschka IMP Institute of Molecular Pathol...
BIOTREE a leading biopharmaceutical engineering and process equipment company in India has rebranded as ZETA Biosystem This change strengthens the companys integration
Alteogen Inc announced on July st that its subsidiary Altos Biologics Inc has submitted Marketing Authorization Application to the European Medicines Agency for an aflibercept biosimilar ALTL developed by Alteogen The Phase clinical trial for ALTL c...
CanFite BioPharma Ltd a biotechnology company with a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases announced
Anbogen Therapeutics Inc a clinicalstage company dedicated to developing breakthrough cancer therapies has announced the successful closing of a USD M oversubscribed A round financing
Eisai Co Ltd announced today that it has agreed to end its global strategic collaboration with Bristol Myers Squibb for the codevelopment and cocommercialization of farletuzumab
CBC Group Asias largest healthcarededicated asset management firm headquartered in Singapore announced that its controlled portfolio company Hasten Biopharmaceutical an innovationdriven
SCG Cell Therapy Pte Ltd a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers today announced that US Food and Drug Administration
